These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10602033)

  • 21. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
    Altes HK; Wodarz D; Jansen VA
    J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance.
    Wodarz D
    J Theor Biol; 2001 Dec; 213(3):447-59. PubMed ID: 11735291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cytotoxic T-lymphocyte response in HIV-1 infection.
    Kalams SA; Walker BD
    Clin Lab Med; 1994 Jun; 14(2):271-99. PubMed ID: 7924192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines.
    Colić M; Lukić A; Vucević D; Milosavljević P; Majstorović I; Marjanović M; Dimitrijević J
    Arch Oral Biol; 2006 Dec; 51(12):1120-30. PubMed ID: 16797478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.
    Ryden A; Stechova K; Durilova M; Faresjö M
    Diabetes Metab Res Rev; 2009 May; 25(4):335-43. PubMed ID: 19382103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
    Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG
    Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells.
    Torres KC; Dutra WO; Gollob KJ
    Hum Immunol; 2004 Nov; 65(11):1328-35. PubMed ID: 15556683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
    McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
    J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
    Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
    Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impairment of the immune system by HIV infection].
    Arndt R; Keeser D
    Z Hautkr; 1989 May; 64(5):353-4, 357-8, 363. PubMed ID: 2525849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
    Stricker RB; McHugh TM; Moody DJ; Morrow WJ; Stites DP; Shuman MA; Levy JA
    Nature; 1987 Jun 25-Jul 1; 327(6124):710-3. PubMed ID: 2955226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell strategies in AIDS vaccines: MHC-restricted T-cell responses to HIV proteins.
    Mills KH; Nixon DF; McMichael AJ
    AIDS; 1989; 3 Suppl 1():S101-10. PubMed ID: 2575396
    [No Abstract]   [Full Text] [Related]  

  • 38. In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy.
    Buseyne F; Le Chenadec J; Burgard M; Bellal N; Mayaux MJ; Rouzioux C; Rivière Y; Blanche S
    AIDS Res Hum Retroviruses; 2005 Aug; 21(8):719-27. PubMed ID: 16131312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune defects in pediatric AIDS, their pathogenesis, and role of immunotherapy.
    Pahwa S
    Crit Care Med; 1990 Feb; 18(2 Suppl):S138-43. PubMed ID: 2153503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination.
    Fujiki F; Oka Y; Kawakatsu M; Tsuboi A; Tanaka-Harada Y; Hosen N; Nishida S; Shirakata T; Nakajima H; Tatsumi N; Hashimoto N; Taguchi T; Ueda S; Nonomura N; Takeda Y; Ito T; Myoui A; Izumoto S; Maruno M; Yoshimine T; Noguchi S; Okuyama A; Kawase I; Oji Y; Sugiyama H
    Anticancer Res; 2010 Jun; 30(6):2247-54. PubMed ID: 20651376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.